中华外科杂志
中華外科雜誌
중화외과잡지
CHINESE JOURNAL OF SURGERY
2010年
2期
99-102
,共4页
汪涛%孙玉鹗%初向阳%姚树林%杨博%田嘉禾%张锦民%范开杰
汪濤%孫玉鶚%初嚮暘%姚樹林%楊博%田嘉禾%張錦民%範開傑
왕도%손옥악%초향양%요수림%양박%전가화%장금민%범개걸
肺肿瘤%正电子发射断层显像术%放射性示踪剂%诊断%鉴别
肺腫瘤%正電子髮射斷層顯像術%放射性示蹤劑%診斷%鑒彆
폐종류%정전자발사단층현상술%방사성시종제%진단%감별
Lung neoplasms%Positron-emission tomography%Radioactive tracers%Diagnosis%differential
目的 探讨胆碱、甲硫氨酸、脱氧胸腺嘧啶核苷、乙酸盐为示踪剂的正电子发射体层显像(PET)在肺部病变诊断中的应用价值.方法 2002年6月至2007年6月对100例肺部占位病变的患者行PET检查.其中~(11)C-胆碱(CH)-PET检查58例,~(11)C-甲硫氨酸(MET)-PET检查16例,~(18)F-脱氧胸腺嘧啶核苷(FLT)-PET检查22例,~(11)C-乙酸盐(AC)-PET检查4例.结果 采用目测法判读,半定量分析法测量病变标准摄取值,结果与病理诊断及随访结果对照.结果CH-PET定性诊断灵敏度、特异度、符合率分别为84.2%(32/38)、57.9%(11/19)、75.4%(43/57).MET-PET定性诊断灵敏度、特异度、符合率分别为6/7、6/9、75.0%(12/16).FLT-PET检查定性诊断灵敏度、特异度、符合率分别为85.7%(12/14)、2/8、63.6%(14/22).CH.PET、MET-PET及FLT-PET中肿瘤标准摄取值与肿瘤大小、患者年龄不相关.AC.PET检查仅1例透明细胞癌肺转移显影,2例鳞状细胞癌、1例腺癌没有显影.结论 这些示踪剂PET对肺部病变的定性诊断有帮助,但存在假阳性和假阴性结果.
目的 探討膽堿、甲硫氨痠、脫氧胸腺嘧啶覈苷、乙痠鹽為示蹤劑的正電子髮射體層顯像(PET)在肺部病變診斷中的應用價值.方法 2002年6月至2007年6月對100例肺部佔位病變的患者行PET檢查.其中~(11)C-膽堿(CH)-PET檢查58例,~(11)C-甲硫氨痠(MET)-PET檢查16例,~(18)F-脫氧胸腺嘧啶覈苷(FLT)-PET檢查22例,~(11)C-乙痠鹽(AC)-PET檢查4例.結果 採用目測法判讀,半定量分析法測量病變標準攝取值,結果與病理診斷及隨訪結果對照.結果CH-PET定性診斷靈敏度、特異度、符閤率分彆為84.2%(32/38)、57.9%(11/19)、75.4%(43/57).MET-PET定性診斷靈敏度、特異度、符閤率分彆為6/7、6/9、75.0%(12/16).FLT-PET檢查定性診斷靈敏度、特異度、符閤率分彆為85.7%(12/14)、2/8、63.6%(14/22).CH.PET、MET-PET及FLT-PET中腫瘤標準攝取值與腫瘤大小、患者年齡不相關.AC.PET檢查僅1例透明細胞癌肺轉移顯影,2例鱗狀細胞癌、1例腺癌沒有顯影.結論 這些示蹤劑PET對肺部病變的定性診斷有幫助,但存在假暘性和假陰性結果.
목적 탐토담감、갑류안산、탈양흉선밀정핵감、을산염위시종제적정전자발사체층현상(PET)재폐부병변진단중적응용개치.방법 2002년6월지2007년6월대100례폐부점위병변적환자행PET검사.기중~(11)C-담감(CH)-PET검사58례,~(11)C-갑류안산(MET)-PET검사16례,~(18)F-탈양흉선밀정핵감(FLT)-PET검사22례,~(11)C-을산염(AC)-PET검사4례.결과 채용목측법판독,반정량분석법측량병변표준섭취치,결과여병리진단급수방결과대조.결과CH-PET정성진단령민도、특이도、부합솔분별위84.2%(32/38)、57.9%(11/19)、75.4%(43/57).MET-PET정성진단령민도、특이도、부합솔분별위6/7、6/9、75.0%(12/16).FLT-PET검사정성진단령민도、특이도、부합솔분별위85.7%(12/14)、2/8、63.6%(14/22).CH.PET、MET-PET급FLT-PET중종류표준섭취치여종류대소、환자년령불상관.AC.PET검사부1례투명세포암폐전이현영,2례린상세포암、1례선암몰유현영.결론 저사시종제PET대폐부병변적정성진단유방조,단존재가양성화가음성결과.
Objective To assess the value of positron emission tomography (PET) with ~(11)C-choline(CH), ~(11)C-methionine ( MET),~(18)F-fluorothymidine ( FLT), and ~(11)C-acetate (AC) in diagnosis of pulmonary abnormalities and the features of pulmonary abnormalities in PET. Methods From June 2002 to June 2007, 100 patients with pulmonary nodules or masses confirmed by CT scans received PET with special tracers. Fifty-eight patients received CH-PET, 16 patients received MET-PET, 22 patients received FLT-PET, 4 patients received AC-PET. PET data was analyzed by visual method and semiquantitative method with standard uptake value (SUV). Diagnoses were compared with pathology and follow-up survey. Results For identification of pulmonary neoplasms with CH-PET, the sensitivity, specificity and accuracy were 84. 2% (32/38), 57. 9% (11/19) and 75.4% (43/57). In cancer cases, SUV had no correlation with tumor size or age. For identification of pulmonary neoplasms with MET-PET, the sensitivity, specificity and accuracy were 6/7, 6/9 and 75.0% (12/16). In cancer cases, SUV had not correlation with tumor size orage. For identification of pulmonary neoplasms with FLT-PET, the sensitivity, specificity and accuracy were 85.7% (12/14), 2/8 and 63.6% (14/22). In cancer cases, SUV had not correlation with tumor size or age. In AC-PET, only 1 case of pulmonary metastasis of kidney clear cell carcinoma showed acetate avid.Two squamous cell carcinoma and 1 adenocarcinoma didn't appear abnormal in AC-PET. Conclusion CH,MET, FLT, AC are valuable in diagnosing but also lead to false positive and false negative.